Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Parkinson's Disease
Location: United States, IL
A multicenter, double blind, randomized, parallel group, placebo controlled study to assess the clinical effect of Droxidopa in the treatment of symptomatic neurogenic orthostatis hypotension in patients with Parkinson's Disease
The purpose of this research study is to determine whether Droxidopa can relieve the symptoms of NOH and whether it causes any side effects in people with symptomatic NOH. Droxidopa is a drug that is changed in the body to a chemical called norepinephrine. Norepinephrine is a chemical in your body that is used by your body’s nervous system to signal nerves that control blood pressure. The study drug that you will take if you are in this study is a capsule that contains either Droxidopa or placebo (an identical-looking pill that does not contain any active drug; a placebo is sometimes called a "sugar pill"). The reason for having people take placebo in this study is to see if taking droxidopa is better than taking placebo.
Please contact Alexian Brothers for more information on participation.
Alexian Brothers Hospital Network
800 Biesterfield Road
Brock Building First Floor
Elk Grove Village, IL 60007
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these